Arkema Shares: Nearly 3% Decline After a Nearly 10% Weekly Rally
Arkema shares fell by 2.68% this Friday morning to €63.60, after gaining nearly 10% over the past week. This decline comes as the price approaches a critical technical zone, on the verge of its major resistance. Over three months, the stock still shows a gain of more than 20%, contrasting with an annual decline of over 20%.
Today's decline in Arkema's stock occurs in a context of notable technical tension. The price, which was at €65.35 the previous day, tested the resistance threshold at €65.45 but failed to break through. This technical rejection partly explains the correction observed this morning. The Relative Strength Index (RSI), a measure of the speed and magnitude of price movements, stands at 88, clearly in the overbought zone. This level, generally above 70, indicates that the stock has experienced rapid appreciation and may be exposed to profit-taking. Meanwhile, the price remains solidly above its 50-day (€52.92) and 200-day (€57.42) moving averages, indicating that a medium-term bullish momentum is still in place despite today's pullback.
Fundamental Dynamics Reflect Mixed Performance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Fundamentally, Arkema's stock market trajectory reflects divergent dynamics depending on the time horizon considered. The 20.68% rise over three months represents a significant recovery for the specialty chemist, driven by a sector rebound and a focus on high-value markets such as adhesives, advanced materials, and high-performance coatings. However, the annual performance remains negative at -20.6%, indicating that the Paris-listed group has not yet erased the entirety of its accumulated decline. The stock also has a very low beta of 0.01, indicating almost no correlation with general market movements in the recent period. Monthly volatility, measured at 15.57, remains moderate for an industrial stock, although the acceleration observed this week could change in the upcoming sessions. No financial calendar events are announced for the group in the short term.
Après des mois de janvier et février relativement faibles, la performance du premier trimestre a finalement été légèrement supérieure aux attentes.
Les volumes du Groupe sont stables, et la demande dans les segments clés est en hausse.
Risks mentioned
Impact potentiel de la crise au Moyen-Orient sur la demande mondiale.
Inflation des coûts des intrants résultant de la crise au Moyen-Orient.
Opportunities identified
Développement dans des marchés clés attractifs tels que les batteries et l'impression 3D.
Poursuite des efforts pour gérer strictement les coûts fixes.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.